Rothschild Investment LLC Anavex Life Sciences Corp. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rothschild Investment LLC holds 235 shares of AVXL stock, worth $2,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 235
-0.0%
Holding current value
$2,072
Previous $2.52 Million
20.13%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AVXL
# of Institutions
188Shares Held
29.2MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$56.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$41.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$21.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16.5 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$10 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $687M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...